Return to Perspectives
COVID-19 Legal Resource Guide
April 28, 2020

Whole Leaf Organics Agrees to Preliminary Order Barring the Making of Unsubstantiated COVID-19, Cancer Treatment Claims

The FTC has filed a complaint against marketer Marc Ching, who began to market a dietary supplement called “Thrive” as an “anti viral wellness booster” beginning on or around March of 2020. In response to the complaint, Ching, who does business as Whole Leaf Organics, agreed to a preliminary order barring him from making unsupported claims that Whole Leaf’s Thrive supplements are effective at treating, preventing and reducing the risk of contracting COVID-19. The order also bars Whole Leaf from making false or deceptive claims that its CBD-EX, CBD-RX, and CBD-Max cannabidiol products are effective cancer treatments. The FTC also approved the issuance of an administrative complaint, which seeks an order permanently halting Ching’s allegedly deceptive advertising for the Thrive and CBD-EX, CBD-RX, and CBD-Max products. The administrative case is set to begin on January 7, 2021.​

View the press release

Authors and Editors

Related Practices

We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.